Kinetic study of serum gentamicin concentrations in baboons after single-dose administration.

J. R. Watson, M. K. Stoskopf, H. Rozmiarek, J. D. Strandberg

Research output: Contribution to journalArticlepeer-review

Abstract

This study establishes preliminary pharmacokinetic data on the use of gentamicin sulfate administered IM to baboons. Serum concentrations greater than or equal to 12 micrograms/ml are generally agreed to cause toxicosis in human beings. On the basis of preliminary test results suggesting that the manufacturer's recommended dosage for dogs of 4.4 mg/kg of body weight caused potentially toxic serum concentrations, a dosage of 3 mg/kg was chosen to conduct a single-dose kinetic study in 6 baboons. Using a single-compartment model, the gentamicin serum half-life for IM administration of 3 mg of gentamicin/kg was 1.58 hours, and serum concentrations remained below the potentially toxic concentrations reported for human beings. We suggest that a dosage of 3 mg/kg is safer than a dosage of 4.4 mg/kg administered IM to baboons. Minimal inhibitory concentrations for 2 Pseudomonas aeruginosa isolates were less than or equal to 1 micrograms/ml. On the basis of our measured elimination half-life of 1.58 hours, it is reasonable to suppose that dosing q24 h will be inadequate to maintain therapeutic serum concentrations. We calculate that serum concentrations will remain at or above our measured minimal inhibitory concentration for P aeruginosa (1 micrograms/ml) for 100% of the treatment time if the animal is dosed q 6h, 78% for dosing q 8h, and 52% for dosing q 12h. Therefore, we suggest 3 mg/kg, q 8h or q 6h as appropriate dosing schedules for the use of gentamicin sulfate administered IM to baboons.

Original languageEnglish (US)
Pages (from-to)1285-1287
Number of pages3
JournalAmerican journal of veterinary research
Volume52
Issue number8
StatePublished - Aug 1991

ASJC Scopus subject areas

  • veterinary(all)

Fingerprint Dive into the research topics of 'Kinetic study of serum gentamicin concentrations in baboons after single-dose administration.'. Together they form a unique fingerprint.

Cite this